Patent Leaderboard
USPTO Patent Rankings Data through Dec 31, 2025
Home › 2-phenyl-3,4-dihydropyrrolo[2,1-f] [1,2,4]triazinone derivatives as phosphodiesterase inhibitors and uses thereof

2-phenyl-3,4-dihydropyrrolo[2,1-f] [1,2,4]triazinone derivatives as phosphodiesterase inhibitors and uses thereof

US Patent 12351585 · Granted Jul 8, 2025

Assignee

Inventors

View full patent text on Google Patents →

More Patents by These Inventors

Dual mode of action soluble guanylate cyclase activators and phosphodiesterase i2025
Dual mode of action soluble guanylate cyclase activators and phosphodiesterase i2025
Dual mode of action soluble guanylate cyclase activators and phosphodiesterase i2024
Dual mode of action soluble guanylate cyclase activators and phosphodiesterase i2024
2-phenyl-3,4-dihydropyrrolo[2,1 -f] [1,2,4]triazinone derivatives as phosphodies2024
2-phenyl-3,4-dihydropyrrolo[2,1 -f] [1,2,4]triazinone derivatives as phosphodies2024
2-phenyl-3,4-dihydropyrrolo[2,1-Ff] [1,2,4]triazinone derivatives as phosphodies2022
2-phenyl-3,4-dihydropyrrolo[2,1-Ff] [1,2,4]triazinone derivatives as phosphodies2022
Dual mode of action soluble guanylate cyclase activators and phosphodiesterase i2021
Dual mode of action soluble guanylate cyclase activators and phosphodiesterase i2021
2-phenyl-3,4-dihydropyrrolo[2,1 -F] [1,2,4]triazinone derivatives as phosphodies2020
2-phenyl-3,4-dihydropyrrolo[2,1 -F] [1,2,4]triazinone derivatives as phosphodies2020